Tafenoquine for the radical cure versus prophylaxis of Plasmodium vivax malaria: the importance of using the appropriate data set

被引：1

作者：

Sharma, Raman ^{[1
]}

Chen, Chao ^{[4
]}

Fita, Ioana-Gabriela ^{[5
]}

Gibson, Rachel A. ^{[2
]}

Jones, Sion ^{[6
]}

Pingle, Anup ^{[8
]}

Rolfe, Katie ^{[3
]}

Sharma, Hema

Bird, Panayota ^{[7
]}

机构：

[1] GSK, Clin Pharmacol Modelling & Simulat, Stevenage, Herts, England

[2] GSK, Global Hlth Med R&D, Stevenage, Herts, England

[3] GSK, Biostat, Stevenage, Herts, England

[4] GSK, Clin Pharmacol Modelling & Simulat, Brentford, Middx, England

[5] GSK, Safety Evaluat & Risk Management, Brentford, Middx, England

[6] GSK, Clin Safety & Pharmacovigilance, Brentford, Middx, England

[7] GSK, Global Hlth, Brentford, Middx, England

[8] GSK, Global Hlth Access, Mumbai, Maharashtra, India

来源：

INDIAN JOURNAL OF MEDICAL RESEARCH | 2023年 / 158卷 / 02期

关键词：

PREVENT RELAPSE; DOUBLE-BLIND; EFFICACY; PRIMAQUINE; TOLERABILITY; REGIMENS; SAFETY; TRIAL;

D O I：

10.4103/ijmr.ijmr_405_23

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：204 / 206

页数：3

共 20 条

[1] Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers
Ackert, Jessica
Mohamed, Khadeeja
Slakter, Jason S.
El-Harazi, Sherif
Berni, Alessandro
Gevorkyan, Hakop
Hardaker, Elizabeth
Hussaini, Azra
Jones, Sion W.
Koh, Gavin C. K. W.
Patel, Jyoti
Rasmussen, Scott
Kelly, Deborah S.
Baranano, David E.
Thompson, John T.
Warren, Keith A.
Sergott, Robert C.
Tonkyn, John
Wolstenholme, Allen
Coleman, Hanna
Yuan, Alex
Duparc, Stephan
Green, Justin A.
[J]. DRUG SAFETY, 2019, 42 (09) : 1103 - 1114
[2] Single loading-dose tafenoquine for malaria chemoprophylaxis during brief travel?
Baird, J. Kevin
[J]. JOURNAL OF TRAVEL MEDICINE, 2021, 28 (05)
[3] Clinical TrialRegistryIndia, TAF112582-A multi-centre, doubleblind, randomised, parallel-group, active-controlled study to evaluate the efficacy, safety and tolerability of tafenoquine (SB-252263,WR238605) in subjects with Plasmodium vivax malaria
[4] The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific
Elmes, N. J.
Nasveld, P. E.
Kitchener, S. J.
Kocisko, D. A.
Edstein, M. D.
[J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2008, 102 (11) : 1095 - 1101
[5] A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria
Fukuda, Mark M.
Krudsood, Srivicha
Mohamed, Khadeeja
Green, Justin A.
Warrasak, Sukhuma
Noedl, Harald
Euswas, Ataya
Ittiverakul, Mali
Buathong, Nillawan
Sriwichai, Sabaithip
Miller, R. Scott
Ohrt, Colin
[J]. PLOS ONE, 2017, 12 (11):
[6] Tafenoquine at therapeutic concentrations does not prolong fridericia-corrected QT interval in healthy subjects
Green, Justin A.
Patel, Apurva K.
Patel, Bela R.
Hussaini, Azra
Harrell, Emma J.
McDonald, Mirna J.
Carter, Nick
Mohamed, Khadeeja
Duparc, Stephan
Miller, Ann K.
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (09) : 995 - 1005
[7] GSK, Highlights of prescribing information
[8] GSK, US FDA approves krintafel (tafenoquine) for the radical cure of P. vivax malaria
[9] Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria - United States, 2019
Haston, Julia C.
Hwang, Jimee
Tan, Kathrine R.
[J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2019, 68 (46): : 1062 - 1068
[10] Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data
Hounkpatin, Aurore B.
Kreidenweiss, Andrea
Held, Jana
[J]. INFECTION AND DRUG RESISTANCE, 2019, 12 : 553 - 570

← 1 2 →